Can we do the BE study of orally disintegrating strip against FC Tablets [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2016-02-29 18:15 (3768 d 07:06 ago) – Posting: # 16041
Views: 2,750

Dear Sofiya
Of course you can investigate comparative bioavailability of an orally disintegrating strip against a film coated tablet since both formulations are immediate release formulations. An orally disintegrating strip is formulated to quickly disintegrate in the mouth. Placement in the mouth and time of contact may be critical in cases where the active substance also is dissolved in the mouth and can be absorbed directly via the buccal mucosa. Depending on the formulation, swallowing of the e.g. coated substance and subsequent absorption from the gastrointestinal tract also will occur. If it can be demonstrated that the active substance is not absorbed in the oral cavity, but rather must be swallowed and absorbed through the gastrointestinal tract, then the product might be considered for a BCS based biowaiver. If this cannot be demonstrated, bioequivalence must be evaluated in human studies.
For further Information see CPMP/EWP/QWP/1401/98 Rev. 1/ Corr ** Appendix 2.
I hope this helps.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
125 visitors (0 registered, 125 guests [including 22 identified bots]).
Forum time: 02:21 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5